Specific Targeting of Melanotic Cells with Peptide Ligated Photosensitizers for Photodynamic Therapy
Open Access
- 16 November 2017
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 7 (1) , 1-12
Abstract
A strategy combining covalent conjugation of photosensitizers to a peptide ligand directed to the melanocortin 1 (MC1) receptor with the application of sequential LED light dosage at near-IR wavelengths was developed to achieve specific cytotoxicity to melanocytes and melanoma (MEL) with minimal collateral damage to surrounding cells such as keratinocytes (KER). The specific killing of melanotic cells by targeted photodynamic therapy (PDT) described in this study holds promise as a potentially effective adjuvant therapeutic method to control benign skin hyperpigmentation or superficial melanotic malignancy such as Lentigo Maligna Melanoma (LMM).Keywords
This publication has 66 references indexed in Scilit:
- Melanoma resistance to photodynamic therapy: new insightsBiological Chemistry, 2013
- Modular nanotransporters: a multipurpose in vivo working platform for targeted drug deliveryInternational Journal of Nanomedicine, 2012
- Aminolevulinic Acid (ALA) as a Prodrug in Photodynamic Therapy of CancerMolecules, 2011
- Transdermal Delivery of ProteinsAAPS PharmSciTech, 2011
- Current states and future views in photodynamic therapyJournal of Photochemistry and Photobiology C: Photochemistry Reviews, 2011
- Effect and Mechanism of a New Photodynamic Therapy with Glycoconjugated FullerenePhotochemistry and Photobiology, 2010
- Imaging and Photodynamic Therapy: Mechanisms, Monitoring, and OptimizationChemical Reviews, 2010
- Photodynamic therapy: update 2006 Part 2: Clinical resultsJournal of the European Academy of Dermatology and Venereology, 2007
- Photodynamic therapy for cancerNature Reviews Cancer, 2003
- Photosensitizer targeting in photodynamic therapy II. Conjugates of haematoporphyrin with serum lipoproteinsJournal of Photochemistry and Photobiology B: Biology, 1994